Sealed Air Corporation (NYSE: SEE) announced July 2, that it has completed an acquisition of Virox Technologies’ Accel® brand and its related healthcare businesses in the United States and Canada.
The acquired assets include the brand, the current healthcare business and existing customer relationships. Through its Diversey business, Sealed Air has had a long standing exclusive, global relationship with Virox and this new arrangement will enhance Diversey’s marketing of Virox’s proprietary Accelerated Hydrogen Peroxide® (AHP®) technology.
“We see a unique opportunity to leverage Virox’s patented technology and Professional and Technical Services (PTS) model around the world to deliver thought leadership in the cleaning and disinfecting arena,” said Ilham Kadri, President of Sealed Air’s Diversey Division. “Their PTS model leveraged with our sales coverage, application expertise, and global distribution will create an environment for the success of our AHP- based solutions in the Oxivir® brand globally.”
Virox CEO, Randy Pilon states, “Virox has a long standing relationship with Diversey and our combined healthcare business now puts Diversey in a leading position for knowledge-based solutions in surface disinfection in the healthcare sector in Canada. The plan is to replicate this success in the United States and become the infection prevention resource to healthcare professionals so that all the sectors supported by Diversey will feel confident in choosing their infection prevention solutions.”
AHP is a patented, synergistic blend of commonly used, safe ingredients, that when combined with low levels of hydrogen peroxide dramatically increase its disinfecting and cleaning ability. It provides the unique benefits of speed and efficacy, while being gentle on people, surfaces and the environment.